Blachly JS, Walter RB, Hourigan CS. The present and future of measurable residual disease testing in acute myeloid leukemia. haematol [Internet]. 2022Dec.1 [cited 2024Nov.24];107(12):2810-22. Available from: https://haematologica.org/article/view/haematol.2022.282034